Published in Hum Brain Mapp on April 01, 2010
A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage (2011) 6.60
Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals. Neuroimage (2010) 1.69
Degeneration and repair in central nervous system disease. Nat Med (2010) 1.42
Identifying abnormal connectivity in patients using dynamic causal modeling of FMRI responses. Front Syst Neurosci (2010) 1.16
Injury and repair in the neurovascular unit. Neurol Res (2012) 0.93
Altered default-mode network activation in mild cognitive impairment compared with healthy aging. Neuroradiology (2012) 0.92
Loss of motor function in preclinical Alzheimer's disease. Expert Rev Neurother (2011) 0.91
Widespread disruption of functional brain organization in early-onset Alzheimer's disease. PLoS One (2014) 0.85
Evidence of altered corticomotor system connectivity in early-stage Alzheimer's disease. J Neurol Phys Ther (2012) 0.83
Reduced interhemispheric inhibition in mild cognitive impairment. Exp Brain Res (2012) 0.80
Intra- and inter-cortical motor excitability in Alzheimer's disease. J Neural Transm (Vienna) (2011) 0.77
Functional Magnetic Resonance Imaging Methods. Neuropsychol Rev (2015) 0.76
Modulation of APOE and SORL1 genes on hippocampal functional connectivity in healthy young adults. Brain Struct Funct (2017) 0.76
The age-related posterior-anterior shift as revealed by voxelwise analysis of functional brain networks. Front Aging Neurosci (2014) 0.75
Predicting Individual Brain Functional Connectivity Using a Bayesian Hierarchical Model. Neuroimage (2016) 0.75
Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art. Front Psychol (2015) 0.75
Altered Functional Connectivity of Cognitive-Related Cerebellar Subregions in Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N Engl J Med (2010) 13.82
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med (2006) 7.18
Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature (2003) 5.31
Randomized trial of oral teriflunomide for relapsing multiple sclerosis. N Engl J Med (2011) 4.93
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet (2013) 4.62
Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann Neurol (2008) 4.15
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N Engl J Med (2010) 4.08
Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature (2005) 3.53
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Placebo-controlled trial of oral laquinimod for multiple sclerosis. N Engl J Med (2012) 3.16
Comparison of fingolimod with interferon beta-1a in relapsing-remitting multiple sclerosis: a randomised extension of the TRANSFORMS study. Lancet Neurol (2011) 3.16
Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol (2008) 3.03
Neuroanatomical correlates of behavioural disorders in dementia. Brain (2005) 2.92
Unravelling Boléro: progressive aphasia, transmodal creativity and the right posterior neocortex. Brain (2007) 2.75
Different regional patterns of cortical thinning in Alzheimer's disease and frontotemporal dementia. Brain (2007) 2.72
Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63
Evidence for acute neurotoxicity after chemotherapy. Ann Neurol (2010) 2.45
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Structural anatomy of empathy in neurodegenerative disease. Brain (2006) 2.28
Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy. Arch Neurol (2006) 2.27
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol (2009) 2.20
Connected speech production in three variants of primary progressive aphasia. Brain (2010) 2.19
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 2.13
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10
White matter damage in frontotemporal dementia and Alzheimer's disease measured by diffusion MRI. Brain (2009) 2.08
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol (2012) 2.05
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol (2005) 2.01
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis. Neurology (2012) 2.00
Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet (2004) 1.93
Neuroimaging studies of word and pseudoword reading: consistencies, inconsistencies, and limitations. J Cogn Neurosci (2003) 1.92
Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain (2009) 1.89
Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol (2005) 1.82
Progressive nonfluent aphasia and its characteristic motor speech deficits. Alzheimer Dis Assoc Disord (2007) 1.78
Setting a research agenda for progressive multiple sclerosis: the International Collaborative on Progressive MS. Mult Scler (2012) 1.75
TDP-43 frontotemporal lobar degeneration and autoimmune disease. J Neurol Neurosurg Psychiatry (2013) 1.74
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage (2010) 1.71
Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol (2012) 1.70
Resting state fMRI in Alzheimer's disease: beyond the default mode network. Neurobiol Aging (2011) 1.70
Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol (2002) 1.68
Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain (2008) 1.67
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett (2011) 1.64
Early hemorrhagic transformation of brain infarction: rate, predictive factors, and influence on clinical outcome: results of a prospective multicenter study. Stroke (2008) 1.63
Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke (2006) 1.63
Anterior temporal cortex and semantic memory: reconciling findings from neuropsychology and functional imaging. Cogn Affect Behav Neurosci (2006) 1.60
Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J Neurosci (2009) 1.59
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry (2013) 1.58
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler (2011) 1.57
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology (2012) 1.57
Automated MRI-based classification of primary progressive aphasia variants. Neuroimage (2009) 1.55
The Italian Brain Normative Archive of structural MR scans: norms for medial temporal atrophy and white matter lesions. Aging Clin Exp Res (2009) 1.53
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord (2010) 1.52
Language networks in semantic dementia. Brain (2009) 1.50
Brain network connectivity assessed using graph theory in frontotemporal dementia. Neurology (2013) 1.50
Weighing brain activity with the balance: Angelo Mosso's original manuscripts come to light. Brain (2013) 1.50
Apraxia of speech: an overview. Neurocase (2005) 1.49
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A (2009) 1.49
Cortical lesions in multiple sclerosis. Nat Rev Neurol (2010) 1.47
Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study. J Neurol (2013) 1.47
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol (2010) 1.46
White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology (2010) 1.46
A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology (2009) 1.45
A tensor based morphometry study of longitudinal gray matter contraction in FTD. Neuroimage (2007) 1.45
A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol (2009) 1.41
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol (2006) 1.40
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Ann Neurol (2003) 1.39
Anatomical correlates of sentence comprehension and verbal working memory in neurodegenerative disease. J Neurosci (2007) 1.39
Migralepsy: a new case confirming the existence of this migraine complication and proposing therapy. Neurol Sci (2012) 1.39
Spontaneous intracerebral hemorrhage in Urbach-Wiethe disease. Neurology (2012) 1.39
Patent foramen ovale closure and brain ischaemic lesions. Heart (2013) 1.39
Detecting sarcasm from paralinguistic cues: anatomic and cognitive correlates in neurodegenerative disease. Neuroimage (2009) 1.38